Pelvic Inflammatory Disease in an IUD User: Setting, Regimen, and the IUD Question
Amara, 23, G0, presents to your clinic on a Tuesday afternoon with 4 days of worsening lower abdominal pain and a yellow vaginal discharge. She had a 52-mg levonorgestrel IUD placed 14 months ago. Temperature is 38.4 C, HR 104, BP 108/68, RR 18. Speculum exam shows mucopurulent cervical discharge; bimanual exam reveals cervical motion tenderness and bilateral adnexal tenderness without a palpable mass. Urine hCG is negative. NAAT for chlamydia and gonorrhea has been sent, with results in 48 hours. She has eaten little today but has kept down water, has no vomiting, and reports a single male partner. She is anxious about the IUD and asks whether it has to come out.
1. Decide whether she can be managed as an outpatient or requires admission, and justify your choice using the specific features of this case.
Read the worked answer
Outpatient management is appropriate. The decision turns on the standard criteria for hospitalization in PID: pregnancy, tubo-ovarian abscess, severe illness or inability to tolerate oral therapy, a diagnosis that cannot be made without inpatient evaluation, and surgical emergencies.
Against those criteria:
- Urine hCG is negative, making ectopic pregnancy unlikely (a serum hCG is reasonable if there is any doubt).
- There is no adnexal mass on bimanual exam, so no evidence of a tubo-ovarian abscess. If she has not improved in 48-72 hours, obtain a transvaginal ultrasound.
- Temperature 38.4 C and HR 104 are modest; she is tolerating oral fluids, has no vomiting, and shows no signs of sepsis (BP 108/68, RR 18).
- She meets the minimum clinical criteria for PID: cervical motion tenderness and adnexal tenderness, plus fever and mucopurulent discharge.
What must be in place: reliable follow-up in 48-72 hours, the ability to return, and explicit return precautions (worsening pain, vomiting, syncope, fever above 39 C). Document why appendicitis, ovarian torsion, and tubo-ovarian abscess are unlikely, and reassess at follow-up.
2. Write the empiric regimen you would prescribe today, with doses, and explain what each component covers.
Read the worked answer
Treat empirically today; do not wait for the NAAT results.
Regimen (CDC outpatient PID):
- Ceftriaxone 500 mg IM once (1 g if weight 150 kg or more) - gonococcal coverage.
- Doxycycline 100 mg PO twice daily for 14 days - chlamydial coverage and the backbone of PID therapy.
- Metronidazole 500 mg PO twice daily for 14 days - anaerobes and bacterial vaginosis-associated organisms; adding it improves clinical cure.
Counseling that determines whether this works:
- Doxycycline with a full glass of water, remaining upright for 30 minutes, and separating dairy, antacids, and iron by 2 hours; warn about photosensitivity. It is not contraindicated here because she is not pregnant.
- No alcohol with metronidazole.
- Complete all 14 days even after symptoms resolve; abbreviated courses are associated with treatment failure.
- Draw HIV and syphilis serologies today and offer hepatitis B vaccination if she is not immune.
If she cannot tolerate oral therapy or deteriorates, switch to inpatient IV cefotetan or cefoxitin plus doxycycline.
3. She repeats her question about the IUD. What do you tell her, and what follow-up and partner management do you arrange?
Read the worked answer
The IUD can stay. Removal does not improve PID outcomes and is not required; the elevated PID risk is tied to the insertion event, not to continued use. Explaining this plainly usually resolves the anxiety and prevents an unnecessary removal.
Follow-up and partner management:
- Phone or in-person check in 48-72 hours; examine her if she is not improving by 72 hours.
- NAAT results at 48 hours - treat or adjust; add trichomonas testing if discharge persists.
- Retest for chlamydia and gonorrhea at 3 months, because reinfection is common.
- Treat all partners from the 60 days before symptom onset (or the most recent partner if longer than 60 days) empirically with ceftriaxone plus doxycycline plus metronidazole; abstain from intercourse until she and her partner complete therapy.
- Counsel about the long-term stakes: recurrent PID increases the risk of tubal factor infertility, ectopic pregnancy, and chronic pelvic pain. This is a concrete motivator for condom use and for prompt evaluation of any future pelvic pain.